<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/~/media/Files/S/staar-surgical/XSL/rss_xsl.xsl"?> 
<rss version="2.0" xmlns:dt="http://xsltsl.org/date-time">
 <channel>
  <title>RSS - Staar Surgical - Press Releases </title>
  <link>https://investors.staar.com/rss/press-releases</link>
  <language>en</language>
<webMaster>Staar Surgical</webMaster>
<image>
<url>https://investors.staar.com/~/media/Images/S/staar-surgical/logo/logo-dark.svg</url>
</image>
<item>
<title><![CDATA[STAAR Surgical Reports Third Quarter 2026 Results]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO™ family of Implantable Collamer ® Lenses for vision correction, today reported results for the third quarter ended October 2, 2026. The Company will host an earnings call and webcast today at 5:30 PM Eastern Time. Net sales down 12% Y/Y; up 21% excluding a 33- percentage point impact from...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/11-04-2026-210207920</link>
<pubDate>Wed, 04 Nov 2026 20:01:00 GMT</pubDate>
<publishDate>Wed, 04 Nov 2026 21:05:43 GMT</publishDate>
<guid>{AC5C1C37-A05E-473B-93CF-29AFF41AB169}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced the appointment of Pascal Aeschlimann as Vice President of Asia Pacific, effective November 2, 2026. Aeschlimann, who led STAAR’ s commercial expansion across Asia and the Middle East from 2002 to 2010, returns...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/10-29-2026-110314743</link>
<pubDate>Thu, 29 Oct 2026 10:01:00 GMT</pubDate>
<publishDate>Thu, 29 Oct 2026 11:03:16 GMT</publishDate>
<guid>{F39A7E97-71D4-4BD7-9888-558030FBC90E}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical to Participate in Upcoming Investor Conferences]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO™ family of Implantable Collamer ® Lenses for vision correction, today announced that Warren Foust, President and Chief Executive Officer, and Deborah Andrews, Executive Vice President and Chief Financial Officer, will participate in two investor conferences in November:.]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/10-27-2026-200129551</link>
<pubDate>Tue, 27 Oct 2026 19:01:00 GMT</pubDate>
<publishDate>Tue, 27 Oct 2026 20:01:31 GMT</publishDate>
<guid>{A8DFF438-A6E9-4E61-A581-40B6E5D58698}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that it will release financial results and a letter to shareholders for the third quarter ended October 2, 2026, on Wednesday, November 4, 2026, after the market close. The Company will also host an earnings call...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/10-21-2026-210113498</link>
<pubDate>Wed, 21 Oct 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 21 Oct 2026 21:01:16 GMT</publishDate>
<guid>{FE46D89B-C67D-48C9-930D-34126FD33B8F}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Names Andrew Pilon as Vice President of Business Development]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced the appointment of Andrew Pilon, O.D. as Vice President of Business Development. Pilon will report to STAAR President and Chief Executive Officer Warren Foust and will work closely with the Company’ s senior...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/10-08-2026-201416848</link>
<pubDate>Thu, 08 Oct 2026 20:14:00 GMT</pubDate>
<publishDate>Thu, 08 Oct 2026 20:14:18 GMT</publishDate>
<guid>{ECD4BB26-6D5F-4FC4-B484-4C6BB3DAF2DC}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Board Approves $50 Million Share Repurchase Authorization]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO™ family of Implantable Collamer ® Lenses for vision correction, today announced that its Board of Directors, at a regularly scheduled meeting, authorized a share repurchase program under which the Company may repurchase up to $50 million of its outstanding common stock.]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-24-2026-210110425</link>
<pubDate>Thu, 24 Sep 2026 21:01:00 GMT</pubDate>
<publishDate>Thu, 24 Sep 2026 21:01:12 GMT</publishDate>
<guid>{EF8BD713-73AC-4A63-9B58-8043D34C2705}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction]]></title>
<description><![CDATA[The report examines patient sentiment, procedure volume trends, and clinical practice patterns across Japan, China, South Korea, the United States, Germany, Spain, and the UK and Ireland. The STAAR Surgical team will be available to discuss the results of the report at the upcoming 44th Congress of the ESCRS in London from September 11– 15, 2026, where the Company...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-10-2026-120022923</link>
<pubDate>Thu, 10 Sep 2026 12:00:00 GMT</pubDate>
<publishDate>Thu, 10 Sep 2026 12:00:25 GMT</publishDate>
<guid>{883CA235-B69A-47D1-8840-E3242E791C70}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced the appointment of David Bailey as Chief Commercial Officer.  "As our former President and CEO, he launched commercialization of the ICL across Asia and championed development of the central port, the innovation...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-08-2026-203320099</link>
<pubDate>Tue, 08 Sep 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 09 Sep 2026 20:33:21 GMT</publishDate>
<guid>{7175C232-331D-41E3-94C7-0A2FC2B86B55}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced the appointment of Ben Park, Ph.D., as Chief Technology Officer. Park will join STAAR's Executive Committee and report to Warren Foust, President and Chief Executive Officer. Park built and led a global...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/09-02-2026-210122542</link>
<pubDate>Wed, 02 Sep 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 02 Sep 2026 21:01:25 GMT</publishDate>
<guid>{8F9699E1-BDB3-4A95-929B-82C729BE9E03}</guid>
<isalertable>False</isalertable>
</item>
<item>
<title><![CDATA[STAAR Surgical Reports Second Quarter 2026 Results]]></title>
<description><![CDATA[STAAR Surgical Company, the global leader in phakic IOLs with the EVO™ family of Implantable Collamer ® Lenses for vision correction, today reported results for the second quarter ended July 3, 2026.. Second Quarter 2026 Financial Overview. Net sales of $93.5 million, up 111% Y/Y Net sales excluding China of $41.2 million, up 6.0% Y/Y China sales of $52.3 million...]]></description>
<link>https://investors.staar.com/news-and-events/press-releases/2026/08-12-2026-210127260</link>
<pubDate>Wed, 12 Aug 2026 21:01:00 GMT</pubDate>
<publishDate>Wed, 12 Aug 2026 21:02:53 GMT</publishDate>
<guid>{A7330ED6-4D06-4427-9D07-6000A947FF43}</guid>
<isalertable>False</isalertable>
</item>

  
 </channel>
</rss>